Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer

1. Cardone, C.
2. Martinelli, E.
3. Troiani, T.
4. Sforza, V.
5. Avallone, A.
6. Nappi, A.
7. Montesarchio, V.
8. Andreozzi, F.
9. Biglietto, M.
10. Calabrese, F.
11. Bordonaro, R.
12. Cordio, S.
13. Bregni, G.
14. Febbraro, A.
15. Garcia-Carbonero, R.
16. Feliu, J.
17. Cervantes, A.
18. Ciardiello, F.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1136/ESMOOPEN-2019-000519 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus